Peter Lange
#128,630
Most Influential Person Now
Medical researcher
Peter Lange's AcademicInfluence.com Rankings
Peter Langelaw Degrees
Law
#2343
World Rank
#2923
Historical Rank
Common Law
#86
World Rank
#94
Historical Rank
International Law
#462
World Rank
#581
Historical Rank
Download Badge
Law
Peter Lange's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Biomedical Sciences Harvard University
Similar Degrees You Can Earn
Why Is Peter Lange Influential?
(Suggest an Edit or Addition)Peter Lange's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A 15-year follow-up study of ventilatory function in adults with asthma. (1998) (1245)
- Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study (2006) (1040)
- Prognostic value of nutritional status in chronic obstructive pulmonary disease. (1999) (1032)
- Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial (1999) (812)
- Once‐Daily Single‐Inhaler Triple versus Dual Therapy in Patients with COPD (2018) (759)
- Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. (1996) (722)
- Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. (2006) (605)
- Developing COPD: a 25 year follow up study of the general population (2006) (591)
- Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. (2015) (526)
- C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. (2007) (525)
- Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. (1997) (443)
- Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. (2007) (405)
- Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. (2012) (400)
- Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. (2013) (363)
- Dose of jogging and long-term mortality: the Copenhagen City Heart Study. (2015) (342)
- Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. (2016) (313)
- Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? (2002) (300)
- Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study (2002) (294)
- Chronic mucus hypersecretion in COPD and death from pulmonary infection. (1995) (277)
- Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study (2003) (264)
- Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. (2001) (259)
- Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. (1999) (259)
- Decline of lung function in adults with bronchial asthma. (1994) (220)
- Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. (2012) (209)
- Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. (1990) (208)
- European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency (2017) (198)
- Change in Lung Function and Morbidity from Chronic Obstructive Pulmonary Disease in 1-Antitrypsin MZ Heterozygotes: A Longitudinal Study of the General Population (2002) (187)
- Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. (1989) (186)
- Mortality in women and men in relation to smoking. (1998) (156)
- Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. (2015) (149)
- Effects of smoking and changes in smoking habits on the decline of FEV1. (1989) (146)
- Potential misclassification of causes of death from COPD (2006) (143)
- Long-term physical activity in leisure time and mortality from coronary heart disease, stroke, respiratory diseases, and cancer. The Copenhagen City Heart Study (2006) (141)
- Rehabilitation of patients with chronic obstructive pulmonary disease. Exercise twice a week is not sufficient! (2000) (140)
- A Comparison of the Assessment of Quality of Life with CAT, CCQ, and SGRQ in COPD Patients Participating in Pulmonary Rehabilitation (2012) (139)
- Changes in physical activity and all-cause mortality in COPD (2014) (135)
- Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults (2002) (132)
- Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. (2019) (131)
- Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. (2011) (127)
- Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Copenhagen City Heart Study Group. (1997) (127)
- Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. (2001) (125)
- Inhaled corticosteroids and decline of lung function in community residents with asthma (2006) (121)
- Spirometric findings and mortality in never-smokers. (1990) (120)
- Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. (2016) (119)
- Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. (2006) (118)
- Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? (2002) (115)
- Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. (1990) (115)
- Longevity in male and female joggers: the Copenhagen City Heart Study. (2013) (112)
- Mortality in adults with self-reported asthma (1996) (108)
- Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. (1995) (106)
- The Patient's Perspective: Adherence or Non-adherence to Asthma Controller Therapy? (2006) (106)
- Resting heart rate is a predictor of mortality in COPD (2012) (105)
- Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. (2013) (104)
- Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. (2017) (97)
- Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population (2001) (95)
- Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. (1991) (94)
- ΔF508 heterozygosity in cystic fibrosis and susceptibility to asthma (1998) (94)
- Diagnosis, assessment, and phenotyping of COPD: beyond FEV1 (2016) (94)
- Chronic obstructive lung disease in Copenhagen: cross‐sectional epidemiological aspects (1989) (91)
- Statin use and exacerbations in individuals with chronic obstructive pulmonary disease (2014) (88)
- Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts (2012) (88)
- Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen City Heart Study. (1995) (87)
- Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease (2007) (87)
- Asthma progression and mortality: the role of inhaled corticosteroids (2019) (83)
- Risk Factors for Chronic Cough Among 14,669 Individuals From the General Population (2017) (83)
- Perceived stress and risk of adult‐onset asthma and other atopic disorders: a longitudinal cohort study (2012) (82)
- Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease (2020) (82)
- Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis (2018) (78)
- Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease (2013) (77)
- Diabetes mellitus and ventilatory capacity: a five year follow-up study. (1990) (76)
- C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach (2010) (76)
- Characteristics and Prognosis of Never-Smokers and Smokers with Asthma in the Copenhagen General Population Study. A Prospective Cohort Study. (2015) (76)
- [Smoking and asthma]. (2002) (75)
- Symptoms of sleep disordered breathing and risk of cancer: a prospective cohort study. (2013) (75)
- Gender and Smoking‐Related Risk of Lung Cancer (1998) (75)
- Increase in prevalence and severity of asthma in young adults in Copenhagen (2000) (74)
- Accelerated extracellular matrix turnover during exacerbations of COPD (2015) (72)
- Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses (2015) (69)
- Lung mucociliary clearance (1994) (68)
- Time-dependent confounding in the study of the effects of regular physical activity in chronic obstructive pulmonary disease: an application of the marginal structural model. (2008) (68)
- COPD stage and risk of hospitalization for infectious disease. (2008) (67)
- The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls. (2007) (67)
- Prevalence of COPD in Copenhagen. (2011) (66)
- Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD. (2016) (66)
- Pulmonary function is influenced by heavy alcohol consumption. (1988) (65)
- Changes in smoking habits and risk of asthma: a longitudinal population based study. (2001) (65)
- Cardiovascular Morbidity in COPD: A Study of the General Population (2011) (64)
- Ranking of psychosocial and traditional risk factors by importance for coronary heart disease: the Copenhagen City Heart Study. (2015) (64)
- Low Use and Adherence to Maintenance Medication in Chronic Obstructive Pulmonary Disease in the General Population (2014) (64)
- Combined effect of lung function level and decline increases morbidity and mortality risks (2012) (62)
- Cigarette smoking and asthma. (2001) (61)
- Long‐term Effects of 1‐Year Maintenance Training on Physical Functioning and Health Status in Patients With COPD: A Randomized Controlled Study (2010) (60)
- The quality of COPD care in general practice in Denmark: the KVASIMODO study. (2007) (60)
- Spirometric findings as predictors of survival (2010) (59)
- Gastro‐esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease (2015) (59)
- Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. (2018) (57)
- Decline of the lung function related to the type of tobacco smoked and inhalation. (1990) (56)
- High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD – results from the ECLIPSE study (2016) (55)
- Chronic bronchitis in an elderly population. (2003) (55)
- Compliance with LTOT and consumption of mobile oxygen. (1999) (55)
- A simple algorithm for the identification of clinical COPD phenotypes (2017) (53)
- Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. (2001) (53)
- Longitudinal studies of active and passive smoking. (1996) (53)
- A Systematic Review of Resistance Training Versus Endurance Training in COPD (2015) (52)
- Relationship of the type of tobacco and inhalation pattern to pulmonary and total mortality. (1992) (51)
- Vital prognosis after hospitalization for COPD: a study of a random population sample. (1998) (50)
- Danish Register of chronic obstructive pulmonary disease (2016) (50)
- A combination of resistance and endurance training increases leg muscle strength in COPD (2015) (49)
- New Danish reference values for spirometry (2013) (46)
- Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study (2019) (46)
- Shuttle Walking Test as Predictor of Survival in Chronic Obstructive Pulmonary Disease Patients Enrolled in a Rehabilitation Program (2010) (45)
- [The Copenhagen City Heart Study. Joggers live longer]. (2000) (45)
- Prevalence of night-time dyspnoea in COPD and its implications for prognosis (2014) (44)
- Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity (2003) (44)
- Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study (2018) (44)
- Impact of persistence and non-persistence in leisure time physical activity on coronary heart disease and all-cause mortality: The Copenhagen City Heart Study (2017) (44)
- Prevalence and severity of self-reported asthma in young adults, 1976–2004 (2009) (43)
- Various Leisure‐Time Physical Activities Associated With Widely Divergent Life Expectancies: The Copenhagen City Heart Study (2018) (42)
- Socioeconomic Status and Prognosis of COPD in Denmark (2014) (40)
- Association of Blood Eosinophil and Blood Neutrophil Counts with Asthma Exacerbations in the Copenhagen General Population Study. (2017) (40)
- Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry (2019) (40)
- Blood Eosinophils and Exacerbations in COPD: the Copenhagen General Population Study. (2015) (40)
- Geographic variation in long-term oxygen therapy in Denmark : factors related to adherence to guidelines for long-term oxygen therapy. (2001) (40)
- Improved survival prediction from lung function data in a large population sample. (2009) (40)
- Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. (2007) (40)
- Determinants of Smoking Cessation in Patients With COPD Treated in the Outpatient Setting. (2016) (38)
- Overweight and Obesity May Lead to Under-diagnosis of Airflow Limitation: Findings from the Copenhagen City Heart Study (2015) (37)
- Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital (2009) (37)
- Sex differences between women and men with COPD: A new analysis of the 3CIA study. (2020) (36)
- Rehabilitation in COPD: the long-term effect of a supervised 7-week program succeeded by a self-monitored walking program (2008) (36)
- EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. (2008) (36)
- Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion. (2001) (36)
- Importance of Early COPD In Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study. (2020) (35)
- Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality. (2020) (35)
- Natural history of COPD: Focusing on change in FEV1 (2016) (35)
- Chronic obstructive pulmonary disease and cancer risk: a Danish nationwide cohort study. (2012) (34)
- Validation of the i-BODE Index as a Predictor of hospitalization and Mortality in Patients with COPD Participating in Pulmonary Rehabilitation (2014) (34)
- Lung function impairment increases with age of diagnosis in adult onset asthma. (2015) (34)
- Natural history and mechanisms of COPD (2021) (33)
- Quality of COPD care in hospital outpatient clinics in Denmark: The KOLIBRI study. (2009) (33)
- Characteristics of undertreatment in COPD in the general population. (2013) (33)
- Effect of endurance versus resistance training on quadriceps muscle dysfunction in COPD: a pilot study (2016) (33)
- Why do patients decline participation in offered pulmonary rehabilitation? A qualitative study (2017) (32)
- Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. (1996) (32)
- Trends in long-term oxygen therapy for COPD in Denmark from 2001 to 2010. (2014) (32)
- The impact of the Danish Oxygen Register on adherence to guidelines for long-term oxygen therapy in COPD patients. (2006) (32)
- [Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study]. (2007) (32)
- Development and prognosis of chronic obstructive pulmonary disease with special reference to the role of tobacco smoking. An epidemiologic study. (1992) (31)
- The European Respiratory Society spirometry tent: a unique form of screening for airway obstruction (2012) (30)
- Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study (2005) (28)
- Longevity and gray hair, baldness, facial wrinkles, and arcus senilis in 13,000 men and women: the Copenhagen City Heart Study. (1998) (28)
- Vitamin D Status in Patients With Chronic Obstructive Pulmonary Disease Who Participate in Pulmonary Rehabilitation (2011) (28)
- Diagnostic and therapeutic process and prognosis in suspected lung cancer. (1999) (28)
- The 24 Hour Lung Function Time Profile of Olodaterol Once Daily Versus Placebo and Tiotropium in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (2014) (28)
- Improving quality of care among COPD outpatients in Denmark 2008–2011 (2013) (28)
- Role and Impact of Chronic Cough in Individuals with Asthma From the General Population. (2019) (27)
- Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD (2018) (26)
- Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients. (2020) (26)
- PEEP-masks in patients with severe obstructive pulmonary disease: a negative report. (1990) (26)
- Young and middle-aged adults with airflow limitation according to lower limit of normal but not fixed ratio have high morbidity and poor survival: a population-based prospective cohort study (2018) (26)
- Characterization of serological neo-epitope biomarkers reflecting collagen remodeling in clinically stable chronic obstructive pulmonary disease. (2016) (26)
- Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition. (2015) (26)
- Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease The Copenhagen General Population Study (2020) (26)
- Effect of endurance versus resistance training on local muscle and systemic inflammation and oxidative stress in COPD (2018) (25)
- Prognostic Value of C-Reactive Protein, Leukocytes, and Vitamin D in Severe Chronic Obstructive Pulmonary Disease (2014) (25)
- L o n g - t e r m effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised c o n t r o l l e dt r i a l (1999) (25)
- Substantial need for early diagnosis, rehabilitation and treatment of chronic obstructive pulmonary disease. (2012) (25)
- Prevalence, Characteristics, and Prognosis of Early COPD: The Copenhagen General Population Study. (2019) (25)
- Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap (2020) (24)
- C-reactive Protein as a Predictor of Prognosis in COPD. (2006) (24)
- Reference equations for pulmonary diffusing capacity of carbon monoxide and nitric oxide in adult Caucasians (2018) (24)
- Lung-Function Trajectories and Chronic Obstructive Pulmonary Disease. (2015) (24)
- BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy (2004) (23)
- Outdoor activity and performance status as predictors of survival in hypoxaemic chronic obstructive pulmonary disease (COPD) (2005) (23)
- Obese individuals experience wheezing without asthma but not asthma without wheezing: a Mendelian randomisation study of 85 437 adults from the Copenhagen General Population Study (2015) (23)
- Smoking, Systemic Inflammation, and Airflow Limitation: A Mendelian Randomization Analysis of 98 085 Individuals from the General Population. (2019) (23)
- The long-term effect of ambulatory oxygen in normoxaemic COPD patients (2013) (22)
- Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD. (2015) (22)
- Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial (2021) (22)
- Chronic cough in individuals with COPD: a population-based cohort study. (2020) (22)
- Body Mass, Fat Free Body Mass and Prognosis in COPD Patients from a Random Population Sample. (2005) (22)
- Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease (2018) (22)
- Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial (2017) (21)
- Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis. (2021) (20)
- Factor V leiden homozygosity, dyspnea, and reduced pulmonary function. (2005) (20)
- [Diet and lung cancer]. (2003) (19)
- Prognosis of COPD depends on severity of exacerbation history: A population-based analysis. (2019) (19)
- Tablet computers to support outpatient pulmonary rehabilitation in patients with COPD (2016) (18)
- The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial (2020) (18)
- Impact of diagnostic criteria on the prevalence of COPD (2013) (18)
- General practitioners’ perceptions of COPD treatment: thematic analysis of qualitative interviews (2016) (17)
- Chronic obstructive pulmonary disease and risk of infection. (2009) (17)
- U-Shaped Association Between Duration of Sports Activities and Mortality: Copenhagen City Heart Study. (2021) (17)
- Prevention of COPD exacerbations: medications and other controversies (2015) (17)
- Biomarkers of collagen turnover are related to annual change in FEV1 in patients with chronic obstructive pulmonary disease within the ECLIPSE study (2017) (17)
- The effect of inhaled terbutaline on FEV1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung disease. (1992) (17)
- The use of healthcare resources in the last 3 years of life in patients with COPD and lung cancer in Denmark. A retrospective nationwide study (2014) (16)
- The effect of exacerbation history on outcomes in the IMPACT trial (2020) (16)
- The 24-h FEV1 time profile of olodaterol QD delivered via Respimat® in COPD: Results from two 6-week studies (2013) (16)
- FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease (2020) (16)
- Are patients on long‐term oxygen therapy followed up properly? Data from the Danish Oxygen Register (2001) (15)
- High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study. (2016) (15)
- The impact of birth weight on the level of lung function and lung function decline in the general adult population. The Inter99 study. (2015) (15)
- Persistent airway obstruction in asthma. (2013) (15)
- [Developing COPD--25 years follow-up study of the general population]. (2006) (15)
- Midlife cardiorespiratory fitness and the long-term risk of chronic obstructive pulmonary disease (2019) (14)
- A sensitivity analysis of secular trends in risk factors and mortality based on cohort studies. (1999) (14)
- Quality of care and clinical outcomes of chronic obstructive pulmonary disease in patients with schizophrenia. A Danish nationwide study (2018) (14)
- Outcomes of acute exacerbations in COPD in relation to pre-hospital oxygen therapy (2015) (14)
- Fibrinogen and α1-antitrypsin in COPD exacerbations (2015) (13)
- Economic Burden of COPD by Disease Severity – A Nationwide Cohort Study in Denmark (2021) (13)
- Chronic care for COPD patients in Denmark. (2012) (13)
- Cost‐effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark – Cost‐effectiveness analysis based on five randomised controlled trials (2009) (13)
- The effect of home oxygen therapy on hospitalization in moderate hypoxaemic COPD (2005) (13)
- Management of asthma in adults: do the patients get what they need--and want? (2007) (13)
- [Does smoking increase the degree of wrinkles on the face? The Osterbro study]. (1991) (13)
- Non-continuous home oxygen therapy: utilization, symptomatic effect and prognosis, data from a national register on home oxygen therapy. (2001) (12)
- Exhaled CO, a predictor of lung function? (2007) (12)
- Health Outcomes Associated with Lung Function Decline and Respiratory Symptoms and Disease in a Community Cohort (2011) (12)
- Study on drug costs associated with COPD prescription medicine in Denmark (2013) (11)
- Has risk associated with smoking increased? Results from the Copenhagen Center for Prospective Population Studies. (1997) (11)
- Cystic Fibrosis ΔF508 Heterozygotes, Smoking, and Reproduction: Studies of 9141 Individuals from a General Population Sample (1998) (11)
- A BOLD statement on how to case-find moderate/severe COPD (2013) (11)
- Majority of never-smokers with airflow limitation do not have asthma: the Copenhagen General Population Study (2016) (11)
- Psychosocial Risk Factors for Hospitalisation and Death from Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study (2015) (11)
- Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT (2018) (11)
- Prognosis of patients with alpha1-antitrypsine deficiency on long-term oxygen therapy. (2014) (11)
- Targeting small airways in asthma: improvement in clinical benefit? (2011) (11)
- Disease Variability in Asthma: How Do the Patients Respond?–And Why? (2008) (11)
- Danish respiratory society position paper: palliative care in patients with chronic progressive non-malignant lung diseases (2018) (10)
- δF508 heterozygosity and asthma (1998) (10)
- Determinants of chronic mucus hypersecretion in a general population with special reference to the type of tobacco smoked. (1989) (10)
- Use of non-invasive ventilation is increasing in patients admitted with a chronic obstructive pulmonary disease exacerbation. (2013) (10)
- Prognosis of adult asthma. (1999) (10)
- Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries. (2013) (10)
- Phlegm production in plain cigarette smokers who changed to filter cigarettes or quitted smoking (1990) (10)
- Beta-blocker, aspirin and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark. (2019) (10)
- Risk and impact of chronic cough in obese individuals from the general population (2021) (10)
- Fractional exhaled nitric oxide as a determinant for the clinical course of asthma: a systematic review (2021) (10)
- Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study (2018) (10)
- Leg blood flow is impaired during small muscle mass exercise in patients with COPD. (2017) (10)
- Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studies. (2021) (9)
- [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study]. (2000) (9)
- Multiple Score Comparison: a network meta-analysis approach to comparison and external validation of prognostic scores (2017) (9)
- Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort (2020) (9)
- External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study (2019) (9)
- Fletcher and Peto 40 Years On. A Tribute and Reflection. (2017) (8)
- Muscle α-adrenergic responsiveness during exercise and ATP-induced vasodilation in chronic obstructive pulmonary disease patients. (2018) (7)
- Comorbidity Clusters and Healthcare Use in Individuals With COPD (2020) (7)
- Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data (2020) (7)
- Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study (2020) (6)
- β2-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study (2019) (6)
- InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations (2021) (6)
- Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial (2020) (6)
- Supernormal lung function and risk of COPD: A contemporary population-based cohort study (2021) (6)
- Symptoms and quality of life in patients with chronic obstructive pulmonary disease treated with aclidinium in a real-life setting (2016) (6)
- Blood eosinophil counts and treatment response in COPD: analyses of IMPACT (2018) (6)
- [Chronic expectoration and risk of death in chronic obstructive lung disease]. (1996) (6)
- Cystic fibrosis Delta F508 heterozygotes, smoking, and reproduction: studies of 9141 individuals from a general population sample. (1998) (6)
- [Forced expiratory volume in 1 second (FEV1)--a respiratory physiological measurement of considerable prognostic value]. (1991) (6)
- Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults (2015) (5)
- Impact of pre-enrolment medication use on clinical outcomes in SUMMIT (2019) (5)
- Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial (2020) (5)
- Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (2020) (5)
- Management of chronic obstructive pulmonary disease in general practice in Denmark. (2020) (5)
- Beta-blocker, aspirin and statin usage after myocardial infarction in patients with and without COPD. A nationwide analysis from 1995 to 2015 in Denmark (2018) (5)
- Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study (2020) (5)
- GOLD COPD categories are not fit for purpose in primary care--authors' reply. (2013) (5)
- Chronic obstructive pulmonary disease stage and risk of hospitalization for infectious disease. (2008) (5)
- Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial. (2021) (5)
- Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population. (2021) (5)
- Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? (2019) (4)
- Occupational exposures and exacerbations of asthma and COPD—A general population study (2020) (4)
- [Carriers of cystic fibrosis are more susceptible to asthma. The Osterbro study]. (1999) (4)
- Discordant diagnostic criteria for pneumonia in COPD trials: a review (2021) (4)
- Treatment and evaluation of patients with acute exacerbation of asthma before and during a visit to the ER in Denmark (2008) (4)
- Chronic Mucus Hypersecretion and the Natural History of Chronic Obstructive Pulmonary Disease. (2016) (4)
- nceRegular Physical Activity reduces Hospital Admission and Mortality in Chronic Obstructive Pulmonary Disease. A Population-Based Cohort Study (2006) (4)
- Reduction in the Risk of All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol Compared to Umeclidinium/Vilanterol in IMPACT Including Previously Missing or Censored Vital Status Data (2019) (4)
- Reducing socioeconomic inequalities in COPD care in the hospital outpatient setting - A nationwide initiative. (2017) (4)
- [Prevalence of asthma among young adults in Copenhagen]. (2001) (4)
- Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis (2021) (4)
- [Joggers live longer. The Osterbro study]. (2001) (4)
- Nose and blood pressure. Authors' reply (2004) (3)
- Disease self-management in patients with moderate COPD: a thematic analysis (2020) (3)
- Danish general practitioners’ management of patients with COPD: a nationwide survey (2020) (3)
- DELTA F508 HETEROZYGOSITY AND ASTHMA. AUTHORS' REPLY (1998) (3)
- Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial (2022) (3)
- Diet and lung cancer. (2003) (3)
- Exacerbation outcomes with LAMA/LABA and ICS/LABA in high risk COPD patients in the IMPACT trial (2018) (3)
- A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial (2021) (3)
- [Chronic obstructive pulmonary disease. World COPD Day 2002]. (2002) (3)
- pulmonary disease: a population based cohort study admission and mortality in chronic obstructive Regular physical activity reduces hospital (2007) (3)
- COPD drugs: the urgent need for innovation. (2014) (3)
- Occupational inhalant exposures and longitudinal lung function decline (2021) (3)
- [Tobacco, lung cancer and chronic obstructive lung disease. Results from the Osterbro study]. (1993) (3)
- The IMPACT Trial: Single Inhaler Triple Therapy fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Analysis According to Smoking Status (2019) (2)
- LATE-BREAKING ABSTRACT: Blood eosinophils and exacerbations in chronic obstructive pulmonary disease: The copenhagen general population study (2015) (2)
- Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study (2020) (2)
- [The course of pulmonary function in adults with asthma. The Osterbro study]. (2000) (2)
- Validation of lung density indices by cardiac CT for quantification of lung emphysema (2018) (2)
- Re-assessing the importance of FEV1decline (2015) (2)
- Impact of chronic cough in individuals with COPD: a population-based cohort study (2019) (2)
- Chlamydia pneumoniae and chronic obstructive pulmonary disease: bronchial biopsies (PCR and culture) and specific serum antibodies in patients and controls (2000) (2)
- Erratum to: Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease (2011) (2)
- Comparison of LAMA/LABA vs. ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial (2018) (2)
- InforMing the PAthway of COPD Treatment Single-Inhaler Triple Therapy (Fluticasone Furoate/ Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium /Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. (2020) (2)
- Tobaksrygning og asthma (2002) (2)
- [Rehabilitation on chronic obstructive pulmonary disease (COPD). The Danish Society of Pulmonary Medicine]. (2004) (2)
- Cardiorespiratory responses to high‐intensity skeletal muscle metaboreflex activation in chronic obstructive pulmonary disease (2020) (2)
- [Are obesity and overweight risk factors of asthma?]. (2001) (2)
- [Rehabilitation of patients with chronic obstructive pulmonary disease. Effect of a 7-week programme after 12 months]. (2007) (2)
- Prognosis of Patients with COPD Not Eligible for Major Clinical Trials. (2022) (2)
- The long-lasting dark shadow of past and present smoking. (2019) (2)
- [Teenagers with asthma. A qualitative survey among teenagers with asthma of their expectations and attitudes when it comes to offered health care services]. (2002) (2)
- [Rehabilitation of patients with chronic obstructive lung disease. Are two exercise sessions per week sufficient?]. (2000) (2)
- Management of patients with chronic obstructive lung disease, Type 2 diabetes and both diseases in primary care in Denmark. (2020) (2)
- Chronic m mucus h hypersecretion iin C COPD a and d death ffrom pulmonary iinfection (1995) (2)
- [Obese asthma patients have poorer asthma control]. (2015) (2)
- Effect of Theophylline and Salbutamol on Hepatic Drug Metabolism (1989) (2)
- PRS23 Economic Burden of COPD By Disease Severity - a Nationwide Cohort Study in Denmark (2020) (1)
- Longitudinal changes in regular physical activity (PA) in subjects with and without COPD: Findings from the Copenhagen City heart study (2013) (1)
- [Oxygen inhalation therapy at home]. (1996) (1)
- TREATMENT EFFECTS OF FF/UMEC/VI VS FF/VI AND UMEC/VI IN REVERSIBLE AND NONREVERSIBLE COPD PATIENTS: ANALYSES OF THE IMPACT STUDY (2018) (1)
- Misinterpretation of time-to-first event curves can lead to inappropriate treatment (2019) (1)
- [The quality of asthma treatment in Denmark. How far are we--and how far are our patients?]. (2008) (1)
- [Asthma and chronic obstructive lung disease. Prevention and treatment]. (2000) (1)
- Real life management of chronic obstructive pulmonary disease (COPD) in general practice (GP) in Denmark (2015) (1)
- Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study (2014) (1)
- [Global strategy when it comes to chronic obstructive lung disease]. (2001) (1)
- Chronic productive cough and inhalant occupational exposure–a study of the general population (2021) (1)
- [Various types of tobacco smoking and development of chronic obstructive pulmonary disease. Results from the Osterbro study]. (1991) (1)
- [Mortality in adults with asthma. Results from the Osterbro study]. (1997) (1)
- FF/UMEC/VI versus FF/VI and UMEC/VI in the ELLIPTA device in patients with COPD: Subgroup analyses from the IMPACT trial (2018) (1)
- [Fraction of exhaled nitric oxide as biomarker of asthmatic airway inflammation]. (2019) (1)
- Accuracy of Airflow Obstruction Thresholds for Predicting COPD-Related Hospitalization and Mortality: Can Simple Diagnostic Thresholds Be Used for a Complex Disease? (2019) (1)
- Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis. (2022) (1)
- Witnessed sleep apneas together with elevated plasma glucose are predictors of COPD exacerbations (2020) (1)
- Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients (2022) (1)
- The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Efficacy across multiple COPD endpoints over time (2019) (1)
- Authors’ response to Young and Hopkins: vitamin D and lung function (2014) (1)
- Poor prognosis in young and middle-aged adults with airflow limitation according to lower limit of normal but not fixed ratio: a population-based prospective cohort study (2018) (1)
- RISK OF DEATH AND COPD HOSPITALIZATION WITH FLUTICASONE FUROATE-CONTAINING THERAPY: POST HOC SUBGROUP ANALYSIS FROM THE SUMMIT TRIAL IN PATIENTS WITH COPD AND A HISTORY OF EXACERBATION (2020) (1)
- Natural history of development of airflow limitation (2014) (1)
- The drug costs associated with COPD prescription medicine in Denmark (2012) (1)
- [Therapeutic and prognostic course in patients with suspected lung cancer. Results of combined thoracic surgery-pulmonary medicine evaluation]. (1998) (1)
- Prediction of the clinical course of COPD using the old and the new GOLD classification (2012) (1)
- Nose and blood pressure. (2004) (1)
- Medication Adherence In Chronic Obstructive Pulmonary Disease (2011) (1)
- Plasma IgE and risk of exacerbation and mortality in COPD in the general population (2022) (1)
- O009 RED BLOOD CELL N-3 FATTY ACID AS A MARKER FOR FISH OIL-COMPLIANCE IN CANCER PATIENTS (2008) (0)
- [Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease]. (1996) (0)
- Interpreting blood eosinophil counts in health and obstructive lung disease (2022) (0)
- The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: A Pre-Specified Analysis of Safety According to Age (2019) (0)
- Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial. (2022) (0)
- The IMPACT Trail: Single Inhaler Triple Therapy vs. dual therapies: Consistent benefit across multiple exacerbation endpoints (2019) (0)
- InforMing the PAthway of COPD Treatment (The IMPACT Study): Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: An Analysis Based on Baseline COPD Medication Use (2019) (0)
- [Risk factors of death and hospitalization due to pneumonia. Results from the Osterbro study]. (1997) (0)
- COPD Assessment Test (CAT) Score Is Associated with Risk of Future Exacerbation: An Analysis from the IMPACT Trial (2019) (0)
- Working group on epidemiology & prevention of the european society of cardiology (1998) (0)
- The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Results on Cardiovascular Safety (2019) (0)
- Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial (2019) (0)
- Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (2022) (0)
- Identification of patients coded with COPD , pneumonia , and respiratory failure in the DNPR (2011) (0)
- The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Results on Rescue Use and Night-Time Awakenings (2019) (0)
- Increasing difference in survival between women and men from 2001 to 2010: Data from the Danish oxygen register (2013) (0)
- Azithromycin and Hydroxychloroquine in hospitalized patients with confirmed SARS-CoV-2 infection - a randomized placebo-controlled trial (ProPAC-COVID Trial) (2021) (0)
- Do clinical traits differ between GINA 2020 Steps 4 and 5 in primary versus secondary care? (2021) (0)
- Productive vs non-productive chronic cough associated with worse lung health and higher morbidity and mortality in the general population (2022) (0)
- Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease–A Nationwide, Population-Based Cohort Study (2023) (0)
- The impact on future risk of one moderate COPD exacerbation in GOLD A patients – a cohort study (2022) (0)
- Plasma Immunoglobulin E and Risk of Exacerbation and Mortality in COPD: A Contemporary Population-Based Cohort. (2022) (0)
- The authors reply. (2013) (0)
- Potential clinical implications of targeted spirometry for detection of COPD: A contemporary population-based cohort study. (2022) (0)
- [Beta 2 agonists: are they dangerous?]. (1992) (0)
- O-71 Occupational inhalant exposures and longitudinal lung function decline (2021) (0)
- Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD (2012) (0)
- Single inhaler triple therapy in patients with COPD: response rates in health-related quality of life in the IMPACT Trial (2018) (0)
- Effects of smoking and changes in smoking habits (2012) (0)
- [Fluticasone propionate--a new inhalation steroid for the treatment of bronchial asthma]. (1996) (0)
- The pathogenic consequences of a single mutated CFTR gene (1999) (0)
- [Expectoration--an underestimated symptom?]. (1993) (0)
- Relation ofventilatory impairment andofchronic mucus hypersecretion tomortality from obstructive lungdisease andfromall causes (2011) (0)
- Characteristics and consequences of chronic obstructive pulmonary disease in never smokers (2013) (0)
- Syddansk Universitet Danish Register of chronic obstructive pulmonary disease (2016) (0)
- Sex differences in COPD outcome in 5,355 women with COPD: A new analysis of the 3CIA study (2020) (0)
- P2442Myocardial performance index predicts mortality in people with obstructive lung function from the general population (2019) (0)
- The effect of n-3-fatty acids on quality of life in patients with lung cancer (2009) (0)
- CHRONIC OBSTRUCTIVE PULMONARY DISEASE Developing COPD: a 25 year follow up study of the general population (2006) (0)
- Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD in the general population (2020) (0)
- Night time dyspnea in COPD: A study of a general population (2013) (0)
- Imaging oftheairways bybronchoscintigra phy forthe study ofmucociliary clearance (1988) (0)
- Role and impact of chronic cough in obese individuals from the general population (2020) (0)
- A systematic review of endurance, resistance and combined exercise training in COPD (2014) (0)
- Tobacco consumption, systemic inflammation, and airflow limitation: a Mendelian randomization analysis of 98085 individuals (2018) (0)
- [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid]. (2000) (0)
- P2074Association between left ventricular diastolic function, pulmonary function and cardiovascular events in the general population (2017) (0)
- The long-term effect of ambulatory oxygen (AO) in normoxaemic COPD patients who participate in pulmonary rehabilitation (PR) and desaturate during exercise. A randomised study (2012) (0)
- Optimizing quality of spirometry may increase power in a large-scale clinical trial of inhaled corticosteroids in COPD (1994) (0)
- THORAXJNL151274 1..2 (0)
- general population Developing COPD: a 25 year follow up study of the (2007) (0)
- [Reversibility test in obstructive lung disease. Use and limitations]. (1994) (0)
- Cost-effectiveness of adding budesonide/formoterol to tiotropium in severe COPD patients in four Nordic countries (2012) (0)
- [Obese asthma patients have poorer asthma control]. (2014) (0)
- Epidemiological aspects of systemic inflammation in COPD (2011) (0)
- DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS EXPERIENCING ON-TREATMENT EXACERBATIONS, ON-TREATMENT DEATH, OR PREMATURE STUDY TREATMENT WITHDRAWAL: THE IMPACT TRIAL (2020) (0)
- Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD? (2000) (0)
- Many obese individuals experience wheezing, rather than asthma. A Mendelian randomization study of 86,019 adults (2015) (0)
- TIME-DEPENDENT RISK OF CARDIOVASCULAR EVENTS FOLLOWING AN EXACERBATION IN PATIENTS WITH COPD: POST HOC ANALYSIS FROM THE IMPACT TRIALl (2020) (0)
- Samtidig iltbehandling ved anstrengelsesudløst hypoksæmi forbedrer den fysiske formåen og reducerer åndenød hos patienter med KOL (2011) (0)
- [The quality of COPD care in general practice]. (2008) (0)
- Challenges in defining early COPD in the general population: Findings from the Copenhagen General Population Study (2020) (0)
- Gastro-oesophageal reflux is a significant predictor of COPD exacerbations (2013) (0)
- TREATMENT EFFECTS OF FF/UMEC/VI VS FF/VI AND UMEC/VI IN COPD PATIENTS BY AIRFLOW LIMITATION SEVERITY: POST-HOC ANALYSES OF THE IMPACT STUDY (2018) (0)
- Sådan får vi styr på lungerne i praksis (2014) (0)
- [Beta 2 agonists: were they nevertheless not dangerous?]. (1994) (0)
- Effect of Alcohol Consumption on Emphysema or Pulmonary function: Reply (1988) (0)
- [Oxygen therapy in exercise-induced hypoxemia improves physical capacity and reduces dyspnea in patients with COPD]. (2011) (0)
- Non-invasive ventilation (NIV) and mortality in patients with a first-time admission for a COPD exacerbation: A nationwide study (2013) (0)
- [Glucocorticoids treatment of exacerbation of chronic obstructive lung diseases]. (2000) (0)
- LATE-BREAKING ABSTRACT: Reference equations for pulmonary diffusing capacity of CO and NO in adult Caucasians (2015) (0)
- Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study (2019) (0)
- Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening (2018) (0)
- Late Breaking Abstract - Risk factors for chronic cough in 14669 individuals from the general population (2017) (0)
- Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients – nationwide data from Denmark (2021) (0)
- [Neuromuscular electrical stimulation improves the functional level in patients with severe chronic obstructive pulmonary disease]. (2013) (0)
- Blood eosinophils and treatment response with triple and dual combination therapy in COPD: analysis of the IMPACT trial (2019) (0)
- Asthma and COPD versus phenotypic traits: Toward precision medicine in chronic airway disease. (2021) (0)
- Reference equations for pulmonary diffusing capacity of CO and NO (2018) (0)
- Changes in physical activity and all-cause mortality in chronic obstructive pulmonary disease (2014) (0)
- Disease modification in COPD — impacting the clinical course (2009) (0)
- Risk charts of five-year mortality in COPD patients (2019) (0)
- [Early supported discharge for patients with exacerbations of chronic obstructive pulmonary disease]. (2008) (0)
- Characteristics and prognosis of never smokers with asthma in the general population (2015) (0)
- Prognosis of COPD according to exacerbation history: a population-based cohort study (2019) (0)
- [Current experiences with liquid oxygen for long term oxygen therapy]. (1998) (0)
- OF AND OCCUPATIONAL EXPOSURES WITH FULL AND PART-TIME SICKNESS ABSENCE: RANDOM AND FIXED (2021) (0)
- [Early diagnosis of COPD is important and possible]. (2013) (0)
- PROGNOSTIC SIGNIFICANCE OF SYMPTOMS IN INDIVIDUALS WITH PRESERVED PULMONARY FUNCTION (2019) (0)
- Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study (2019) (0)
- Prognostic significance of respiratory symptoms in individuals with preserved pulmonary function without known airway disease (2019) (0)
- Vitamin D status in patients with COPD who participate in pulmonary rehabilitation (PR): Characteristics and effects of PR (2011) (0)
- Association of COPD exacerbations with cardiovascular events – a population-based cohort study (2022) (0)
- ‘A Missed Therapeutic Opportunity? SGLT-2 Inhibitor Use in General Medicine Patients With Heart Failure: A Retrospective Audit of Admissions to a Tertiary Health Service’ (2022) (0)
- Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial (2018) (0)
- Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study (2018) (0)
- Medication Adherence And Predictors Of Medication Adherence In Asthma (2011) (0)
- [Diagnostic procedure in patients with suspected lung cancer. Results of combined evaluation by thoracic surgery and pulmonary medicine specialists]. (1998) (0)
- Outcomes consequent to “early” COPD for interventional studies (2020) (0)
- The Copenhagen City Heart Study Experience and its Key Contributions to Chronic Obstructive Pulmonary Disease (2018) (0)
- BENEFIT–RISK PROFILES OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) VS UMEC/VI IN PATIENTS WITH COPD: A MARKOV MODEL (2020) (0)
- causes . from obstructive lung disease and from all chronic mucus hypersecretion to mortality Relation of ventilatory impairment and of (0)
- Gastro-oesophageal reflux disease is a significant predictor of exacerbations in COPD (2013) (0)
- [Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease]. (2008) (0)
- The Editor recommends this issue's articles to the reader (2015) (0)
- Use of heart failure medications in outpatients with COPD and congestive heart failure: a Danish nationwide cohort study (2017) (0)
- Regulation of leg blood flow is impaired during exercise in COPD patients (2017) (0)
- Exposure Interaction: A Lifelong Phenomenon with Relevance to Chronic Obstructive Pulmonary Disease. (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter Lange?
Peter Lange is affiliated with the following schools:
